Eurbio-Alport (RaDiCo Cohort) (RaDiCo Eurbio-Alport)

Plain-language summary

This observational cohort study follows patients with Alport syndrome and examines the course of the disease. It enrolls patients diagnosed with Alport syndrome based on kidney biopsy and/or molecular studies or abnormal type IV collagen findings. It is a study without an assigned phase and is currently recruiting.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Start date

5/9/2017

Estimated completion

6/30/2026

Countries

France

Related genes

Locations

• Paris, France

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Diagnosis of AS based on electron microscopic examination of the renal biopsy and/or molecular studies and/or abnormal expression of type IV collagen chains on skin and/or glomerular basement membranes.
* Signed informed consent

Exclusion Criteria:

\- No exclusion criteria